Replies to post #454854 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Meant do NOT have the reference to hand.

[frrol]

From the Q4 2023 call, the company said it was pursuing "full approval" under the EMA comprehensive procedure. So if approved, we would not have to submit data from a confirmatory study at a later date (it's 'permanent'). It's good to see. I do not know if our MAA will include OLE data. 52 week data from that should be available about the time we submit.